Functional neuroimaging of Cannabidiol in stress and anxiety: a systematic review
This review gathered brain scan studies in adults that gave cannabidiol, a non-intoxicating part of the cannabis plant.
Physiological-behavioural discordance in paediatric perioperative anxiety assessment: a scoping review protocol
Researchers planned a review of published studies on young children who look calm before surgery but show signs of stress inside the body.
Cannabidiol-enriched cannabis extraction product in Parkinson’s disease: A randomized, double-blind, and placebo-controlled trial in Buriram Hospital
This study involved patients diagnosed with Parkinson's disease who were given either a cannabidiol-enriched cannabis product or a placebo.
Assessment of clinical outcomes in patients with post-traumatic stress disorder: analysis from the UK Medical Cannabis Registry
Further research is needed to establish the efficacy and safety of cannabis-based medicinal products in treating PTSD, as current evidence is limited.
Cannabidiol treatment in hand osteoarthritis and psoriatic arthritis: a randomized, double-blind, placebo-controlled trial
Low-dose oral synthetic cannabidiol (20-30 mg daily) failed to provide clinically meaningful pain relief or improve sleep and mood scores compared to.
Assessment of Orally Administered Δ9-Tetrahydrocannabinol When Coadministered With Cannabidiol on Δ9-Tetrahydrocannabinol Pharmacokinetics and Pharmacodynamics in Healthy Adults: A Randomized Clinical Trial
Clinicians should be cautious when prescribing CBD-dominant cannabis products, as they may produce stronger adverse effects than expected.
Acute effects of cannabigerol on anxiety, stress, and mood: a double-blind, placebo-controlled, crossover, field trial
Cannabigerol (CBG) may be a promising option for reducing anxiety and stress in healthy adults without causing impairment or significant side effects.
Cannabis oil extracts for chronic pain: what else can be learned from another structured prospective cohort?
Sublingual THC:CBD oil extracts administered at modest, individually titrated daily doses (around 20 mg each) provided statistically significant.
Acute and Extended Anxiolytic Effects of Cannabidiol in Cannabis Flower: A Quasi-Experimental ad libitum Use Study
Consider recommending CBD-dominant cannabis for patients with anxiety symptoms, as it may provide greater relief compared to THC-dominant options.
A scoping review of the use of cannabidiol in psychiatric disorders
While cannabidiol (CBD) demonstrates a favorable safety profile and preliminary signals of efficacy in psychosis and anxiety.
